Characteristic
COMIRNATY
Placebo
Sex (%)
Male
51.4
50.3
Female
48.6
49.7
Age group (%)
16 through 64 years
79.1
79.2
65 years or older
20.9
20.8
Race or ethnic group (%)
White
81.9
82.1
Black or African American
9.5
9.6
American Indian or Alaska Native
1.0
0.9
Asian
4.4
4.3
Native Hawaiian or other Pacific Islander
0.3
0.2
Hispanic or Latino
25.6
25.4
Non-Hispanic/Latino
73.9
74.1
Did not report ethnicity
0.5
0.5
Comorbidities (%)
Have 1 or more that increase the risk of severe COVID-19 disease
46.0
45.7
Age at vaccination (years)
Mean
49.8
49.7
Median
51.0
51.0